The USP15 protein has been identified as novel target for therapy against cancer progression, investigators report. In certain settings, the TGF-beta pathway can act as an oncogene, enhancing cancer progression in humans.
The USP15 protein has been identified as novel target for therapy against cancer progression, investigators report. In certain settings, the TGF-beta pathway can act as an oncogene, enhancing cancer progression in humans.